California State Teachers Retirement System (CalSTRS)
CNCE

California State Teachers Retirement System (CalSTRS)’s Concert Pharmaceuticals, Inc. CNCE Stock Holding History

California State Teachers Retirement System (CalSTRS)’s Portfolio CNCE Stock Details CNCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-44,710
Closed -$223K – 3308
2021
Q1 		$223K Hold
44,710
– – ﹤0.01% 2852
2020
Q4 		$565K Buy
44,710
+1,759
+4% +$20.1K ﹤0.01% 2363
2020
Q3 		$422K Buy
42,951
+768
+2% +$7.57K ﹤0.01% 2368
2020
Q2 		$420K Buy
42,183
+1,490
+4% +$14.3K ﹤0.01% 2342
2020
Q1 		$360K Buy
40,693
+7,238
+22% +$71.4K ﹤0.01% 2249
2019
Q4 		$309K Hold
33,455
– – ﹤0.01% 2600
2019
Q3 		$197K Hold
33,455
– – ﹤0.01% 2793
2019
Q2 		$401K Hold
33,455
– – ﹤0.01% 2488
2019
Q1 		$404K Buy
33,455
+870
+3% +$12.8K ﹤0.01% 2423
2018
Q4 		$409K Hold
32,585
– – ﹤0.01% 2406
2018
Q3 		$484K Hold
32,585
– – ﹤0.01% 2475
2018
Q2 		$548K Buy
32,585
+5,435
+20% +$106K ﹤0.01% 2400
2018
Q1 		$622K Sell
27,150
-1,099
-4% -$24.4K ﹤0.01% 2257
2017
Q4 		$731K Sell
28,249
-220
-0.8% -$4.43K ﹤0.01% 2184
2017
Q3 		$420K Sell
28,469
-3,301
-10% -$47.9K ﹤0.01% 2501
2017
Q2 		$443K Sell
31,770
-700
-2% -$10.3K ﹤0.01% 2529
2017
Q1 		$554K Sell
32,470
-1,500
-4% -$18K ﹤0.01% 2428
2016
Q4 		$350K Sell
33,970
-900
-3% -$8.22K ﹤0.01% 2697
2016
Q3 		$353K Buy
34,870
+300
+0.9% +$3.28K ﹤0.01% 2664
2016
Q2 		$388K Buy
34,570
+1,980
+6% +$25.2K ﹤0.01% 2616
2016
Q1 		$445K Buy
32,590
+4,099
+14% +$59K ﹤0.01% 2495
2015
Q4 		$540K Buy
28,491
+501
+2% +$10.9K ﹤0.01% 2382
2015
Q3 		$525K Sell
27,990
-100
-0.4% -$1.7K ﹤0.01% 2389
2015
Q2 		$418K Buy
+28,090
New +$428K ﹤0.01% 2679
2014
Q2 		– Sell
-12,100
Closed -$163K – 3099
2014
Q1 		$163K Buy
+12,100
New +$171K ﹤0.01% 2947

Other funds holding CNCE

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $2.83B AUM 21.61% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

California State Teachers Retirement System (CalSTRS)'s CNCE Position: Q2 2021 in Review

California State Teachers Retirement System (CalSTRS) sold out of Concert Pharmaceuticals, Inc. (CNCE) in Q2 2021, closing a stake of 44,710 shares — an estimated $223K sold.

California State Teachers Retirement System (CalSTRS) first reported a position in CNCE in Q1 2014 and held it in 25 quarters. The position peaked at $731K in Q4 2017. 79 funds tracked by Wall St. Rank hold CNCE as of Q2 2021.

  • California State Teachers Retirement System (CalSTRS) reported no remaining Concert Pharmaceuticals, Inc. position as of Q2 2021 after selling out during the quarter.
  • California State Teachers Retirement System (CalSTRS) sold 44,710 Concert Pharmaceuticals, Inc. shares in Q2 2021, an estimated $223K.
  • California State Teachers Retirement System (CalSTRS) first reported a position in Concert Pharmaceuticals, Inc. in Q1 2014 and held it in 25 quarters.
  • California State Teachers Retirement System (CalSTRS)'s Concert Pharmaceuticals, Inc. position peaked at $731K in Q4 2017.
  • 79 funds tracked by Wall St. Rank held Concert Pharmaceuticals, Inc. as of Q2 2021.

Based on California State Teachers Retirement System (CalSTRS)'s 13F filing for Q2 2021, filed 16 Aug 2021.